{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:59:02Z","timestamp":1790517542424,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.jocn.2004.04.011","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T14:36:57Z","timestamp":1136990217000},"page":"78-83","source":"Crossref","is-referenced-by-count":36,"title":["Riluzole therapy for motor neurone disease: An early Australian experience (1996\u20132002)"],"prefix":"10.1016","volume":"13","author":[{"given":"Margie C.","family":"Zoing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Pamphlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2004.04.011_bib1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(96)91680-3","article-title":"Dose-ranging study of riluzole in amyotrophic lateral sclerosis","volume":"347","author":"Lacomblez","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2004.04.011_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410220503","article-title":"Abnormal glutamate metabolism in amyotrophic lateral sclerosis","volume":"22","author":"Plaitakis","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.04.011_bib3","doi-asserted-by":"crossref","unstructured":"Shaw PJ. Excitotoxicity and motor neurone disease: a review of the evidence. J Neurol Sci 124(Suppl):6\u201313.","DOI":"10.1016\/0022-510X(94)90170-8"},{"key":"10.1016\/j.jocn.2004.04.011_bib4","series-title":"Motor Neurone Disease","first-page":"37","article-title":"Current concepts in the pathogenesis of ALS","author":"Shaw","year":"2002"},{"key":"10.1016\/j.jocn.2004.04.011_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jocn.2004.04.011_bib6","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neurone degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jocn.2004.04.011_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.04.011_bib8","first-page":"7","article-title":"Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis","volume":"68","author":"Rothstein","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jocn.2004.04.011_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis","volume":"330","author":"Bensimon","year":"1994","journal-title":"New Engl J Med"},{"issue":"Suppl 4","key":"10.1016\/j.jocn.2004.04.011_bib10","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1212\/WNL.47.6_Suppl_4.221S","article-title":"Excitotoxicity in ALS","volume":"47","author":"Leigh","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.04.011_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00415-003-1026-z","article-title":"An outcome study of riluzole in amyotrophic lateral sclerosis. A population-based study in Ireland, 1996\u20132000","volume":"250","author":"Traynor","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2004.04.011_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"124","author":"Brooks","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2004.04.011_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/jnnp.61.2.131","article-title":"Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis","volume":"61","author":"Roman","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2004.04.011_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jnnp.74.7.995","article-title":"Prolonged survival in motor neurone disease: a descriptive study of the King\u2019s database 1990\u20132002","volume":"74","author":"Turner","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2004.04.011_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.410410212","article-title":"Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis","volume":"41","author":"Cudkowicz","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2004.04.011_bib16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/pmj.78.926.736","article-title":"Management of motor neurone disease","volume":"78","author":"Howard","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jocn.2004.04.011_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/mus.20115","article-title":"Cytoplasmic body myopathy masquerading as motor neurone disease","volume":"30","author":"Krishnan","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2004.04.011_bib18","first-page":"1","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neurone disease (MND) (Cochrane review)","volume":"2","author":"Miller","year":"2004","journal-title":"The Cochrane Library"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2004.04.011_bib19","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1080\/14660820052415925","article-title":"ALS diagnostic criteria of El Escorial revisited: do they meet needs of clinicians as well as researchers","volume":"1","author":"Belsh","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/j.jocn.2004.04.011_bib20","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1212\/WNL.52.7.1311","article-title":"Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review)","volume":"52","author":"Miller","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2004.04.011_bib21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5694\/j.1326-5377.2003.tb05218.x","article-title":"Motor neurone disease: a Pandora\u2019s box","volume":"178","author":"Kiernan","year":"2003","journal-title":"Med J Aust"},{"issue":"Suppl","key":"10.1016\/j.jocn.2004.04.011_bib22","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/PL00007719","article-title":"Palliative care in amyotrophic lateral sclerosis","volume":"244","author":"Borasio","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2004.04.011_bib23","series-title":"Motor Neurone Disease","first-page":"133","article-title":"Multidisciplinary approach to management and support of patients","author":"Richman","year":"2002"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586805003693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586805003693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T02:05:09Z","timestamp":1586657109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586805003693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0967586805003693"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2004.04.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}